Feiyan Pan

2.5k total citations
66 papers, 2.0k citations indexed

About

Feiyan Pan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Feiyan Pan has authored 66 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Feiyan Pan's work include DNA Repair Mechanisms (17 papers), Epigenetics and DNA Methylation (12 papers) and RNA modifications and cancer (12 papers). Feiyan Pan is often cited by papers focused on DNA Repair Mechanisms (17 papers), Epigenetics and DNA Methylation (12 papers) and RNA modifications and cancer (12 papers). Feiyan Pan collaborates with scholars based in China, United States and Canada. Feiyan Pan's co-authors include Zhigang Guo, Zhigang Hu, Lingfeng He, Jianjun Wang, Janne Soininen, Ji Shen, Chaojun Li, Jani Heino, Bin Xue and Huan Wu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Feiyan Pan

64 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feiyan Pan China 24 1.2k 320 248 242 155 66 2.0k
Hynek Strnad Czechia 31 1.4k 1.2× 331 1.0× 296 1.2× 269 1.1× 90 0.6× 89 2.7k
José‐Luis Martínez‐Guitarte Spain 32 1.3k 1.1× 217 0.7× 301 1.2× 305 1.3× 126 0.8× 73 2.9k
Miran Kim South Korea 31 2.0k 1.7× 285 0.9× 244 1.0× 330 1.4× 54 0.3× 99 3.1k
Yuko Itoh Japan 21 1.2k 1.0× 270 0.8× 139 0.6× 285 1.2× 70 0.5× 76 2.0k
Keng Po Lai Hong Kong 36 1.3k 1.1× 571 1.8× 232 0.9× 520 2.1× 184 1.2× 143 3.9k
Ye Zhao China 26 727 0.6× 334 1.0× 239 1.0× 113 0.5× 113 0.7× 112 2.0k
Xiang Xiao China 29 947 0.8× 253 0.8× 119 0.5× 384 1.6× 304 2.0× 95 2.3k
Xiuju Liu China 24 678 0.6× 290 0.9× 203 0.8× 119 0.5× 112 0.7× 72 2.0k
Ida Perrotta Italy 29 832 0.7× 274 0.9× 166 0.7× 84 0.3× 115 0.7× 100 2.4k
William Ka Fai Tse Japan 32 913 0.8× 261 0.8× 418 1.7× 372 1.5× 120 0.8× 107 2.5k

Countries citing papers authored by Feiyan Pan

Since Specialization
Citations

This map shows the geographic impact of Feiyan Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feiyan Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feiyan Pan more than expected).

Fields of papers citing papers by Feiyan Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feiyan Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feiyan Pan. The network helps show where Feiyan Pan may publish in the future.

Co-authorship network of co-authors of Feiyan Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Feiyan Pan. A scholar is included among the top collaborators of Feiyan Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feiyan Pan. Feiyan Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Jiarong, et al.. (2025). Oxidative Stress Regulates CDH3 Expression in Lung Cancer Cells via OGG1-Mediated SP1 Binding. Antioxidants. 14(3). 332–332. 1 indexed citations
2.
Liu, Yuting, Xinyi Song, Zhigang Hu, et al.. (2025). PCAF-mediated acetylation regulates RAD51 dynamic localization on chromatin during HR repair. EMBO Reports. 26(16). 4100–4123.
3.
Chen, Jiannan, Lian‐Feng Zhao, Wenying Li, et al.. (2025). Glutamine-driven metabolic reprogramming promotes CAR-T cell function through mTOR-SREBP2 mediated HMGCS1 upregulation in ovarian cancer. Journal of Translational Medicine. 23(1). 803–803. 3 indexed citations
4.
Du, Yu, Xinyu Yan, Feiyan Pan, et al.. (2024). APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell Death and Differentiation. 31(4). 431–446. 32 indexed citations
5.
Pan, Feiyan, et al.. (2024). TIPE2: A Candidate for Targeting Antitumor Immunotherapy. The Journal of Immunology. 212(5). 755–763. 3 indexed citations
6.
Liu, Jie, Yan Zhang, Xinping Wang, et al.. (2024). m6A methyltransferase METTL3 promotes non-small-cell lung carcinoma progression by inhibiting the RIG-I-MAVS innate immune pathway. Translational Oncology. 51. 102230–102230. 4 indexed citations
7.
Li, Qianwen, Shan Shao, Chuanjun Shu, et al.. (2023). GAPDH facilitates homologous recombination repair by stabilizing RAD51 in an HDAC1 ‐dependent manner. EMBO Reports. 24(8). e56437–e56437. 6 indexed citations
8.
Xin, Jingyu, Lingfeng He, Zhigang Hu, et al.. (2023). RNA G-Quadruplex within the 5′-UTR of FEN1 Regulates mRNA Stability under Oxidative Stress. Antioxidants. 12(2). 276–276. 9 indexed citations
9.
Shao, Shan, et al.. (2023). Short-Term Starvation Weakens the Efficacy of Cell Cycle Specific Chemotherapy Drugs through G1 Arrest. International Journal of Molecular Sciences. 24(3). 2498–2498. 2 indexed citations
11.
Wu, Ting, Ge Chen, Lianfeng Zhao, et al.. (2022). A novel mechanism for macrophage pyroptosis in rheumatoid arthritis induced by Pol β deficiency. Cell Death and Disease. 13(7). 583–583. 31 indexed citations
12.
Wu, Ting, Rui Liu, Meina Wang, et al.. (2022). Polβ modulates the expression of type I interferon via STING pathway. Biochemical and Biophysical Research Communications. 621. 137–143. 5 indexed citations
13.
Li, Lulu, Ziyu Zhang, Yilan Zhang, et al.. (2021). Small-molecule inhibition of APE1 induces apoptosis, pyroptosis, and necroptosis in non-small cell lung cancer. Cell Death and Disease. 12(6). 503–503. 97 indexed citations
14.
Zhang, Miaomiao, Yongjing Yang, Jing Zhang, et al.. (2021). FEN1 inhibitor synergizes with low-dose camptothecin to induce increased cell killing via the mitochondria mediated apoptotic pathway. Gene Therapy. 29(7-8). 407–417. 5 indexed citations
15.
Wang, Wentao, Xingqi Zhao, Qianwen Li, et al.. (2021). Asymmetrical arginine dimethylation of histone H4 by 8-oxog/OGG1/PRMT1 is essential for oxidative stress-induced transcription activation. Free Radical Biology and Medicine. 164. 175–186. 19 indexed citations
16.
Wang, Meina, Lulu Li, Binghua Li, et al.. (2020). DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation. Oncogene. 39(33). 5507–5519. 17 indexed citations
17.
Wu, Bo, Feifei Liu, Aifen Zhou, et al.. (2020). Experimental evolution reveals nitrate tolerance mechanisms in Desulfovibrio vulgaris. The ISME Journal. 14(11). 2862–2876. 14 indexed citations
18.
Wang, Meina, Lin Lin, Feiyan Pan, et al.. (2019). Enhanced Activity of Variant DNA Polymerase β (D160G) Contributes to Cisplatin Therapy by Impeding the Efficiency of NER. Molecular Cancer Research. 17(10). 2077–2088. 13 indexed citations
19.
Zhu, Hong, Xia Wen, Yilan Zhang, et al.. (2019). Inhibition of AKT Sensitizes Cancer Cells to Antineoplastic Drugs by Downregulating Flap Endonuclease 1. Molecular Cancer Therapeutics. 18(12). 2407–2420. 13 indexed citations
20.
Shen, Ning, Xiao Yu, Feiyan Pan, et al.. (2011). An Early Response Transcription Factor, Egr-1, Enhances Insulin Resistance in Type 2 Diabetes with Chronic Hyperinsulinism. Journal of Biological Chemistry. 286(16). 14508–14515. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026